Professur für Translationale Frauenheilkunde und Geburtshilfe

Long-term survival analysis of the randomized phase II trial investigating the addition of carboplatin to neoadjuvant therapy for triple-negative (TNBC) and HER2-positive early breast cancer (GeparSixto) (2017) Untch M, Schneeweiss A, Salat C, Rezai M, Zahm DM, Klare P, Blohmer JU, et al. Conference contribution Prevalence of Circulating Tumor Cells After Adjuvant Chemotherapy With or Without Anthracyclines in Patients With HER2-negative, Hormone Receptor-positive Early Breast Cancer (2017) Schramm A, Schochter F, Friedl TWP, De Greqorio N, Andergassen U, Alunni-Fabbroni M, Trapp E, et al. Journal article OLAPARIB IN GERMAN ROUTINE CLINICAL PRACTICE - INTERIM RESULTS OF THE NON-INTERVENTIONAL STUDY C-PATROL (2017) Marme F, Sehouli J, Welslau M, Schinkoethe T, El-Balat A, Fasching P, Glowik R, Hilpert F Conference contribution Reliability of an e-PRO Tool of EORTC QLQ-C30 for Measurement of Health-Related Quality of Life in Patients With Breast Cancer: Prospective Randomized Trial (2017) Wallwiener M, Matthies L, Simoes E, Keilmann L, Hartkopf AD, Sokolov AN, Walter CB, et al. Journal article PHIP - a novel candidate breast cancer susceptibility locus on 6q14.1 (2017) Jiao X, Aravidis C, Marikkannu R, Rantala J, Picelli S, Adamovic T, Liu T, et al. Journal article Reproductive profiles and risk of breast cancer subtypes: a multi-center case-only study (2017) Brouckaert O, Rudolph A, Laenen A, Keeman R, Bolla MK, Wang Q, Soubry A, et al. Journal article Patient-reported outcomes (PRO) focused on adverse events (PRO-AEs) in adjuvant and metastatic breast cancer: clinical and translational implications (2017) Stefanovic S, Wallwiener M, Karic U, Domschke C, Katic L, Taran FA, Pesic A, et al. Journal article Gene panel sequencing in familial breast/ovarian cancer patients identifies multiple novel mutations also in genes others than BRCA1/2 (2017) Kraus C, Hoyer J, Vasileiou G, Wunderle M, Lux MP, Fasching P, Krumbiegel M, et al. Journal article Enrichment of putative PAX8 target genes at serous epithelial ovarian cancer susceptibility loci (2017) Kar SP, Adler E, Tyrer J, Hazelett D, Anton-Culver H, Bandera EV, Beckmann M, et al. Journal article Interest in Integrative Medicine Among Postmenopausal Hormone Receptor-Positive Breast Cancer Patients in the EvAluate-TM Study (2017) Hack C, Fasching P, Fehm T, De Waal J, Rezai M, Baier B, Baake G, et al. Journal article